Joe Palandra
Pfizer (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Biosimilars and Bioanalytical Methods, Drug Transport and Resistance Mechanisms, Veterinary Orthopedics and Neurology, Advanced Biosensing Techniques and Applications
Most-Cited Works
- → Breast Cancer Resistance Protein (Bcrp/abcg2) Is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse(2006)159 cited
- → Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe(2008)138 cited
- → Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin(2008)118 cited
- → Highly Specific and Sensitive Measurements of Human and Monkey Interleukin 21 Using Sequential Protein and Tryptic Peptide Immunoaffinity LC-MS/MS(2013)105 cited
- → LC−MS/MS Mediated Absolute Quantification and Comparison of Bile Salt Export Pump and Breast Cancer Resistance Protein in Livers and Hepatocytes across Species(2009)100 cited
- → Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injury(2009)69 cited
- → IL1RL1 asthma risk variants regulate airway type 2 inflammation(2016)63 cited
- → Reduced serum myostatin concentrations associated with genetic muscle disease progression(2017)61 cited
- → Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization(2009)45 cited
- → 2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)(2016)42 cited